Patents by Inventor Weijun Wang

Weijun Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
    Publication number: 20030118673
    Abstract: The invention discloses the use of smilagenin and anzurogenin D in the treatment of cognitive dysfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: January 3, 2003
    Publication date: June 26, 2003
    Inventors: Zongqin Xia, Yaer Hu, Ian Rubin, Jonathan Brostoff, Brian Whittle, Weijun Wang, Phil Gunning
  • Smilagenin and its use
    Publication number: 20030032604
    Abstract: The invention discloses the use of a smilagenin in the treatment of cognitive dysfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: August 26, 2002
    Publication date: February 13, 2003
    Inventors: Zongqin Xia, Ian Rubin, Brian Whittle, Philip Gunning, Yaer Hu, Jonathan Brostoff, Weijun Wang
  • Steroidal sapogenins and their derivatives for treating alzheimer's disease
    Publication number: 20020193317
    Abstract: The invention discloses the use of a number of saponins and sapogenins, notably those of steroidal structure, in the treatment of cognitive disfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: February 15, 2002
    Publication date: December 19, 2002
    Inventors: Zongqin Xia, Yaer Hu, Ian Rubin, Jonathan Brostoff, Brian Whittle, Weijun Wang, Phil Gunning
  • Agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
    Patent number: 6486201
    Abstract: The compound represented by formula (I), in which the substitutes are defined as in the specification and the claims, or their stereoisomers, the process for preparing them, pharmaceutical composition containing them and their use as medicine.
    Type: Grant
    Filed: May 18, 2001
    Date of Patent: November 26, 2002
    Assignee: Institute of Materia Medica, Chinese Academy of Medical Science (CN)
    Inventors: Jiyu Guo, Weijun Wang, Hongju Fang, Qian Liu, Wuyan Zhang, Dali Yin, Sujuan Sun, Ruiwu Liu, Chun Li, Haifan Liu, Donghui Wang
  • Smilagenin and its use
    Publication number: 20010043955
    Abstract: The invention discloses the use of a smilagenin in the treatment of cognitive dysfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: May 25, 2001
    Publication date: November 22, 2001
    Inventors: Zongqin Xia, Ian Rubin, Brian Whittle, Philip Gunning, Yaer Hu, Jonathan Brostoff, Weijun Wang
  • Smilagenin and its use
    Patent number: 6258386
    Abstract: The invention discloses the use of a smilagenin in the treatment of cognitive disfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: July 28, 1999
    Date of Patent: July 10, 2001
    Assignee: Phytopharm PLC
    Inventors: Zongqin Xia, Ian Rubin, Brian Whittle, Philip Gunning, Yaer Hu, Jonathan Brostoff, Weijun Wang